Sparrow was the first hospital in Lansing to offer this device, which is directed at atrial fibrillation patients as an alternative to blood thinners. Atrial fibrillation is the most common form of heart arrhythmia in the U.S. and increases the risk of strokes.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
